Literature DB >> 30520052

Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.

Bilon Khambu1, Tiangang Li2, Shengmin Yan1, Changshun Yu1,3, Xiaoyun Chen1, Michael Goheen1, Yong Li1, Jingmei Lin1, Oscar W Cummings1, Youngmin A Lee4,5, Scott Friedman4, Zheng Dong6,7, Gen-Sheng Feng8, Shangwei Wu9, Xiao-Ming Yin1,3.   

Abstract

Autophagy is important for hepatic homeostasis, nutrient regeneration, and organelle quality control. We investigated the mechanisms by which liver injury occurred in the absence of autophagy function. We found that mice deficient in autophagy because of the lack of autophagy-related gene 7 or autophagy-related gene 5, key autophagy-related genes, manifested intracellular cholestasis with increased levels of serum bile acids, a higher ratio of tauromuricholic acid/taurocholic acid in the bile, increased hepatic bile acid load, abnormal bile canaliculi, and altered expression of hepatic transporters. In determining the underlying mechanism, we found that autophagy sustained and promoted the basal and up-regulated expression of farnesoid X receptor (Fxr) in the fed and starved conditions, respectively. Consequently, expression of Fxr and its downstream genes, particularly bile salt export pump, and the binding of FXR to the promoter regions of these genes, were suppressed in autophagy-deficient livers. In addition, codeletion of nuclear factor erythroid 2-related factor 2 (Nrf2) in autophagy deficiency status reversed the FXR suppression. Furthermore, the cholestatic injury of autophagy-deficient livers was reversed by enhancement of FXR activity or expression, or by Nrf2 deletion.
Conclusion: Together with earlier reports that FXR can suppress autophagy, our findings indicate that autophagy and FXR form a regulatory loop and deficiency of autophagy causes abnormal FXR functionality, leading to the development of intracellular cholestasis and liver injury.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30520052      PMCID: PMC6461497          DOI: 10.1002/hep.30407

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Identification of a chemical tool for the orphan nuclear receptor FXR.

Authors:  P R Maloney; D J Parks; C D Haffner; A M Fivush; G Chandra; K D Plunket; K L Creech; L B Moore; J G Wilson; M C Lewis; S A Jones; T M Willson
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

2.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.

Authors:  B A Laffitte; H R Kast; C M Nguyen; A M Zavacki; D D Moore; P A Edwards
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.

Authors:  Lin Wang; Carol J Soroka; James L Boyer
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.

Authors:  David R Johnson; Sultan S M Habeebu; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2002-03       Impact factor: 4.849

6.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

7.  Farnesoid X receptor regulates bile acid-amino acid conjugation.

Authors:  Parinaz C Pircher; Jennifer L Kitto; Mary L Petrowski; Rajendra K Tangirala; Eric D Bischoff; Ira G Schulman; Stefan K Westin
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

8.  Cholic acid mediates negative feedback regulation of bile acid synthesis in mice.

Authors:  Jia Li-Hawkins; Mats Gåfvels; Maria Olin; Erik G Lund; Ulla Andersson; Gertrud Schuster; Ingemar Björkhem; David W Russell; Gosta Eggertsen
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

9.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

Authors:  Yaping Liu; Jane Binz; Mary Jo Numerick; Steve Dennis; Guizhen Luo; Bhasha Desai; Kathleen I MacKenzie; Traci A Mansfield; Steven A Kliewer; Bryan Goodwin; Stacey A Jones
Journal:  J Clin Invest       Date:  2003-11-17       Impact factor: 14.808

10.  Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.

Authors:  R Wang; M Salem; I M Yousef; B Tuchweber; P Lam; S J Childs; C D Helgason; C Ackerley; M J Phillips; V Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  15 in total

1.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

2.  Diverse Consequences in Liver Injury in Mice with Different Autophagy Functional Status Treated with Alcohol.

Authors:  Shengmin Yan; Jun Zhou; Xiaoyun Chen; Zheng Dong; Xiao-Ming Yin
Journal:  Am J Pathol       Date:  2019-06-11       Impact factor: 4.307

3.  NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly.

Authors:  Feng He; Laura Antonucci; Shinichiro Yamachika; Zechuan Zhang; Koji Taniguchi; Atsushi Umemura; Georgia Hatzivassiliou; Merone Roose-Girma; Miguel Reina-Campos; Angeles Duran; Maria T Diaz-Meco; Jorge Moscat; Beicheng Sun; Michael Karin
Journal:  J Hepatol       Date:  2020-02-24       Impact factor: 25.083

4.  The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors.

Authors:  Bilon Khambu; Honghai Hong; Sheng Liu; Gang Liu; Xiaoyun Chen; Zheng Dong; Jun Wan; Xiao-Ming Yin
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 8.469

Review 5.  Hepatic senescence, the good and the bad.

Authors:  Nazmul Huda; Gang Liu; Honghai Hong; Shengmin Yan; Bilon Khambu; Xiao-Ming Yin
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

Review 6.  Autophagy, Metabolism, and Alcohol-Related Liver Disease: Novel Modulators and Functions.

Authors:  Shengmin Yan; Bilon Khambu; Honghai Hong; Gang Liu; Nazmul Huda; Xiao-Ming Yin
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

Review 7.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

Review 8.  Autophagy in liver diseases: A review.

Authors:  Hui Qian; Xiaojuan Chao; Jessica Williams; Sam Fulte; Tiangang Li; Ling Yang; Wen-Xing Ding
Journal:  Mol Aspects Med       Date:  2021-06-11

9.  Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.

Authors:  Qi Wang; Song Wei; Shun Zhou; Jiannan Qiu; Chenyu Shi; Rui Liu; Haoming Zhou; Ling Lu
Journal:  Immunol Cell Biol       Date:  2019-11-19       Impact factor: 5.126

Review 10.  Nuclear Receptors as Autophagy-Based Antimicrobial Therapeutics.

Authors:  Prashanta Silwal; Seungwha Paik; Sang Min Jeon; Eun-Kyeong Jo
Journal:  Cells       Date:  2020-08-27       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.